Description
Detect SARS-CoV-2 antigens swiftly with COVID-19 Antigen Rapid Test Device. Qualitative in vitro assay for nasal samples within 6 days of symptoms. Authorized for Point of Care settings.
$424.75
(25 Tests/Kit)
Quantity | Discount (%) | Price |
---|---|---|
1 - 24 | — | $424.75 |
25+ | 0.94 % | $420.75 |
Detect SARS-CoV-2 antigens swiftly with COVID-19 Antigen Rapid Test Device. Qualitative in vitro assay for nasal samples within 6 days of symptoms. Authorized for Point of Care settings.
Product Description
The Adenovirus, RSV, and Influenza A+B Combo Rapid Test (Cassette) is a rapid chromatographic immunoassay designed for the qualitative detection of key viral respiratory pathogens in nasopharyngeal swab samples. This comprehensive kit streamlines the diagnostic process, providing fast, reliable results for Adenovirus, RSV, and Influenza A & B. Each kit includes all necessary components for a complete testing process, featuring built-in controls to ensure the proper operation.
What are the benefits of using the Combo Rapid Test Cassette?
- **Comprehensive Screening:** Simultaneously tests for four major respiratory viruses, enhancing diagnostic efficiency.
- **Rapid Results:** Delivers findings in just 15 minutes, facilitating timely patient management.
- **High Accuracy:** Demonstrates exceptional sensitivity and specificity across all parameters, ensuring reliable detection.
Specifications for the Combo Rapid Test Cassette
Equipped with CE Mark/IVD certification, this test kit is a trusted choice for healthcare professionals seeking a multifaceted approach to respiratory virus diagnosis. Its user-friendly design and complete kit components allow for a seamless testing experience.
Why choose the Adenovirus, RSV, and Influenza A+B Combo Rapid Test Cassette?
Select this Combo Rapid Test Cassette for its all-encompassing detection capabilities, quick turnaround time, and dependable results. It's an invaluable tool in the diagnosis and management of viral respiratory infections, contributing to better healthcare outcomes.